Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXM3T6
|
||||
| Drug Name |
(S)-1-[4-(5-Fluoro-3-methyl-benzo[b]thiophen-2-yl)-piperidin-1-yl]-3-(1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL54890
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H27FN2O2S
|
||||
| Canonical SMILES |
Cc1c(sc2ccc(F)cc12)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
| InChI |
InChI=1S/C25H27FN2O2S/c1-16-21-13-18(26)5-6-24(21)31-25(16)17-8-11-28(12-9-17)14-19(29)15-30-23-4-2-3-22-20(23)7-10-27-22/h2-7,10,13,17,19,27,29H,8-9,11-12,14-15H2,1H3/t19-/m0/s1
|
||||
| InChIKey |
IIIYSHZFBXJZLJ-IBGZPJMESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.